Core binding factor β (CBFβ) is retained in the midbody during cytokinesis

Journal of Cellular Physiology

Volumn 229, Issue 10, 2014, Pages 1466-1474

  Lopez Camacho, Cesar ^a   van Wijnen, Andre J ^b   Lian, Jane B ^a   Stein, Janet L ^a   Stein, Gary S ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR BETA; HYBRID PROTEIN; SMALL INTERFERING RNA;

ARTICLE; CELL DIVISION; CELL STRUCTURE; CYTOKINESIS; DOWN REGULATION; HUMAN; HUMAN CELL; POLYPLOIDY; PRIORITY JOURNAL; TELOPHASE; TRANSCRIPTION REGULATION;

CORE BINDING FACTOR BETA SUBUNIT; CYTOKINESIS; CYTOPLASMIC STRUCTURES; EPIGENESIS, GENETIC; HELA CELLS; HUMANS; MYOSIN LIGHT CHAINS; ONCOGENE PROTEINS, FUSION; POLYPLOIDY; PROTEIN BINDING; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION;

EID: 84903441886     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24588     Document Type: Article

References (34)

1. Adya N, Stacy T, Speck NA, Liu PP. 1998. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates. Mol Cell Biol 18:7432-7443.
2. Bravo J, Li Z, Speck NA, Warren AJ. 2001. The leukemia-associated AML1 (Runx1)-CBF beta complex functions as a DNA-induced molecular clamp. Nat Struct Biol 8:371-378.
3. Chen CT, Ettinger AW, Huttner WB, Doxsey SJ. 2013. Resurrecting remnants: the lives of post-mitotic midbodies. Trends Cell Biol 23:118-128.
4. Choi JY, Pratap J, Javed A, Zaidi SK, Xing L, Balint E, Dalamangas S, Boyce B, van Wijnen AJ, Lian JB, Stein JL, Jones SN, Stein GS. 2001. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci USA 98:8650-8655.
5. Chuang LS, Lai SK, Murata-Hori M, Yamada A, Li HY, Gunaratne J, Ito Y. 2012. RUNX3 interactome reveals novel centrosomal targeting of RUNX family of transcription factors. Cell Cycle 11:1938-1947.
6. Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, Nezi L, Protopopov A, Chowdhury D, Pellman D. 2012. DNA breaks and chromosome pulverization from errors in mitosis. Nature 482:53-58.
7. Davis JN, Rogers D, Adams L, Yong T, Jung JS, Cheng B, Fennell K, Borazanci E, Moustafa YW, Sun A, Shi R, Glass J, Mathis JM, Williams BJ, Meyers S. 2010. Association of core-binding factor beta with the malignant phenotype of prostate and ovarian cancer cells. J Cell Physiol 225:875-887.
8. Decordier I, Cundari E, Kirsch-Volders M. 2008. Survival of aneuploid, micronucleated and/or polyploid cells: crosstalk between ploidy control and apoptosis. Mutat Res 651:30-39.
9. Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. 2005. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature 437:1043-1047.
10. Goto H, Yasui Y, Kawajiri A, Nigg EA, Terada Y, Tatsuka M, Nagata K, Inagaki M. 2003. Aurora-B regulates the cleavage furrow-specific vimentin phosphorylation in the cytokinetic process. J Biol Chem 278:8526-8530.
11. Hu CK, Coughlin M, Mitchison TJ. 2012. Midbody assembly and its regulation during cytokinesis. Mol Biol Cell 23:1024-1034.
12. Huang G, Shigesada K, Ito K, Wee HJ, Yokomizo T, Ito Y. 2001. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation. EMBO J 20:723-733.
13. Johnson K, Zhu S, Tremblay MS, Payette JN, Wang J, Bouchez LC, Meeusen S, Althage A, Cho CY, Wu X, Schultz PG. 2012. A stem cell-based approach to cartilage repair. Science 336:717-721.
14. Kanno Y, Kanno T, Sakakura C, Bae SC, Ito Y. 1998. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation. Mol Cell Biol 18:4252-4261.
15. Komatsu S, Yano T, Shibata M, Tuft RA, Ikebe M. 2000. Effects of the regulatory light chain phosphorylation of myosin II on mitosis and cytokinesis of mammalian cells. J Biol Chem 275:34512-34520.
16. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T. 1997. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
17. Kundu M, Javed A, Jeon JP, Horner A, Shum L, Eckhaus M, Muenke M, Lian JB, Yang Y, Nuckolls GH, Stein GS, Liu PP. 2002. Cbfbeta interacts with Runx2 and has a critical role in bone development. Nat Genet 32:639-644.
18. Lacroix B, Maddox AS. 2012. Cytokinesis, ploidy and aneuploidy. J Pathol 226:338-351.
19. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109:113-124.
20. Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS. 1993. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science 261:1041-1044.
21. Lutterbach B, Hou Y, Durst KL, Hiebert SW. 1999. The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor. Proc Natl Acad Sci USA 96:12822-12827.
22. Mendoza-Villanueva D, Deng W, Lopez-Camacho C, Shore P. 2010. The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells. Mol Cancer 9:171.
23. Mi H, Muruganujan A, Casagrande JT, Thomas PD. 2013. Large-scale gene function analysis with the PANTHER classification system. Nat Protoc 8:1551-1566.
24. Nagata T, Gupta V, Sorce D, Kim WY, Sali A, Chait BT, Shigesada K, Ito Y, Werner MH. 1999. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain. Nat Struct Biol 6:615-619.
25. Ogawa E, Inuzuka M, Maruyama M, Satake M, Naito-Fujimoto M, Ito Y, Shigesada K. 1993. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha. Virology 194:314-331.
26. Sasaki K, Yagi H, Bronson RT, Tominaga K, Matsunashi T, Deguchi K, Tani Y, Kishimoto T, Komori T. 1996. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proc Natl Acad Sci USA 93:12359-12363.
27. Shu HB, Li Z, Palacios MJ, Li Q, Joshi HC. 1995. A transient association of gamma-tubulin at the midbody is required for the completion of cytokinesis during the mammalian cell division. J Cell Sci 108(Pt 9):2955-2962.
28. Stein GS, van Wijnen AJ, Stein JL, Lian JB, Montecino M, Choi J, Zaidi K, Javed A. 2000. Intranuclear trafficking of transcription factors: implications for biological control. J Cell Sci 113(Pt 14):2527-2533.
29. Tanaka Y, Fujii M, Hayashi K, Chiba N, Akaishi T, Shineha R, Nishihira T, Satomi S, Ito Y, Watanabe T, Satake M. 1998. The chimeric protein, PEBP2 beta/CBF beta-SMMHC, disorganizes cytoplasmic stress fibers and inhibits transcriptional activation. Oncogene 17:699-708.
30. Tanaka Y, Watanabe T, Chiba N, Niki M, Kuroiwa Y, Nishihira T, Satomi S, Ito Y, Satake M. 1997. The protooncogene product, PEBP2beta/CBFbeta, is mainly located in the cytoplasm and has an affinity with cytoskeletal structures. Oncogene 15:677-683.
31. Vinciguerra P, Godinho SA, Parmar K, Pellman D, D'Andrea AD. 2010. Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. J Clin Invest 120:3834-3842.
32. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 93:3444-3449.
33. Yoshida N, Ogata T, Tanabe K, Li S, Nakazato M, Kohu K, Takafuta T, Shapiro S, Ohta Y, Satake M, Watanabe T. 2005. Filamin A-bound PEBP2beta/CBFbeta is retained in the cytoplasm and prevented from functioning as a partner of the Runx1 transcription factor. Mol Cell Biol 25:1003-1012.
34. Zaidi SK, Young DW, Montecino MA, Lian JB, van Wijnen AJ, Stein JL, Stein GS. 2010. Mitotic bookmarking of genes: a novel dimension to epigenetic control. Nat Rev Genet 11:583-589.